Cinobufagin exerts an antitumor effect in non-small-cell lung cancer by blocking STAT3 signaling

Background: Non-small-cell lung cancer (NSCLC) is the most common histological subtype of lung cancer with significant morbidity and mortality rates worldwide. Cinobufagin, the primary component of Chansu and the major active ingredient of cinobufacini, has attracted widespread attention for its exc...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Sunshun, Ma, Chunbo, Zhou, Feng, Zheng, Hailun, Yang, Lehe, Xiao, Zhongxiang, Zhu, Jiandong, Zhao, Haiyang, Zhao, Chengguang, Xu, Xiaoling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622998/
https://www.ncbi.nlm.nih.gov/pubmed/37928418
http://dx.doi.org/10.7150/jca.86544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622998/
https://www.ncbi.nlm.nih.gov/pubmed/37928418
http://dx.doi.org/10.7150/jca.86544

Ejemplares similares